Decheng Capital, founded in 2012, is a global venture capital firm focused exclusively on the healthcare sector. With offices in Silicon Valley, New York, and Shanghai, the firm manages approximately US$3 billion in total assets. Decheng Capital leverages China's historic growth opportunities in healthcare and global revolutionary innovations in life sciences, concentrating its investments in biopharmaceuticals, genetic sequencing and molecular diagnostics, medical devices, and digital health. The firm has established an unparalleled global healthcare ecosystem, providing entrepreneurs, innovators, and inventors with capital, strategic guidance, and comprehensive post-investment value-added services.